These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7075040)

  • 21. Microcytic anemia.
    Shine JW
    Am Fam Physician; 1997 May; 55(7):2455-62. PubMed ID: 9166144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Soluble transferrin receptor and erythropoietin in chronic disease anemia with or without iron deficiency].
    Díaz de Domingo NB; Lardo MM; Gasparini S; Grinspon D; Cantenys N; Carbia CD; Merelli A; Sánchez Avalos JC
    Medicina (B Aires); 2001; 61(5 Pt 1):552-6. PubMed ID: 11725764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaemia and heart failure: aetiology and treatment.
    Klutstein MW; Tzivoni D
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii7-10. PubMed ID: 16024833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment with low doses of intravenous iron does not modify hemoglobin nor the erythropoietin dosage].
    Fernández-Gallego J; Martín MA; Alonso A; Toledo R
    Nefrologia; 2006; 26(1):143-4. PubMed ID: 16649439
    [No Abstract]   [Full Text] [Related]  

  • 26. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS; Wexler D; Iaina A
    J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited value of zinc protoporphyrin as a marker of iron status in chronic hemodialysis patients.
    Canavese C; Grill A; Decostanzi E; Maddalena E; Barbieri S; Martina G; Fop F; Buglione E; Grechi D; David O; Saitta M; Piccoli G
    Clin Nephrol; 2000 Jan; 53(1):42-7. PubMed ID: 10661481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A method for the investigation of reticuloendothelial iron kinetics in man.
    Bentley DP; Cavill I; Ricketts C; Peake S
    Br J Haematol; 1979 Dec; 43(4):619-24. PubMed ID: 526443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia is an important finding and is likely to respond to iron therapy.
    Wright CM; Summerfield GP; Moy R
    Pediatrics; 2005 Nov; 116(5):1258-9; author reply 1259. PubMed ID: 16264019
    [No Abstract]   [Full Text] [Related]  

  • 31. Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients.
    Kwan JT; Pratt RD;
    Curr Med Res Opin; 2007 Feb; 23(2):307-11. PubMed ID: 17288685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anemia in chronic congestive heart failure: frequency, prognosis, and treatment.
    Crosato M; Steinborn W; Anker SD
    Heart Fail Monit; 2003; 4(1):2-6. PubMed ID: 12808478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Peculiarities of ferrorkinetis in adolescent girls with iron-deficiency anemia].
    Mamaeva SM; Omarov A; Kantaeva DK
    Vopr Pitan; 2007; 76(4):38-40. PubMed ID: 17802774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anemia of chronic disease in patients with rheumatoid arthritis--use of zinc protoporphyrin (ZPP) levels.
    Saravana S; Rai A
    J Rheumatol; 2007 Feb; 34(2):446; author reply 446-7. PubMed ID: 17304666
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythropoietin and iron.
    Sunder-Plassmann G; Hörl WH
    Clin Nephrol; 1997 Mar; 47(3):141-57. PubMed ID: 9105761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaemia and heart failure: statement of the problem.
    Lewis BS; Karkabi B; Jaffe R; Yuval R; Flugelman MY; Halon DA
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii3-6. PubMed ID: 16024830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients.
    Labonia W; Rubio D; Arias C
    Nephrology (Carlton); 2005 Dec; 10(6):583-7. PubMed ID: 16354241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viewpoint: Heart failure and anaemia--a concept returns to the fore.
    Shaw R
    Circulation; 2006 Oct; 114(15):f157-8. PubMed ID: 17030699
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyporesponsiveness to erythropoietic therapy due to chronic inflammation.
    Macdougall IC; Cooper AC
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():32-5. PubMed ID: 16281956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.